|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of early gastrointestinal neuroendocrine neoplasms显示文摘Neuroendocrine neoplasms (NENs) of the stomach, duo- denum, appendix or rectum that are small (≤ 1 cm) and well differentiated can be considered 'early' tumors, since they generally have a (very) good prognosis. In the new WHO classification of 2010, these neoplasms are called neuroendocrine tumors/ carcinoids (NETs), grade (G) 1 or 2, and distinguished from poorly differentiated neuroendocrine carcinomas (NECs), G3. NETs are increasing, with a rise in the age-adjusted incidence in the U.S.A. by about 700 % in the last 35 years. Improved early detection seems to be the main reason for these epidemiological changes. Both the better generalavailability of endoscopy, and imaging techniques, have led to a shift in the discovery of smaller-sized (≤ 10-20 mm) intestinal NETs/carcinoids and earlier tumor stages at diagnosis. Endoscopic screening is therefore effective in the early diagnosis, not only of colorectal adenocarcinomas, but also of NETs/carcinoids. Endoscopic removal, followed up with endoscopic surveillance is the treatment of choice in NETs/carcinoids of the stomach, duodenum and rectum that are ≤ 10 mm in size, have a low proliferative activity (G1), do not infiltrate the muscular layer and show no angioinvasion. In all the other intestinal NENs, optimal treatment generally needs surgery and/or medical therapy depending on type, biology and stage of the tumor, as well as the individual situation of the patient. | Hans Scherübl Robert T Jensen Guillaume Cadiot Ulrich Stlzel Günter Klppel | 2011 | World Journal of Gastrointestinal Endoscopy2011，3，7： | 13 |
| 2 | Neuroendocrine tumors of the small bowels are on the rise:Early aspects and management显示文摘Neuroendocrine tumors of the small bowel are on the rise. In the US they have increased by 300%-500% in the last 35 years. At the same time their prognosis is much improved. Today,most neuroendocrine tumors (NETs) of the duodenum are detected 'incidentally' and therefore recognized at an early stage. Duodenal NETs which are well differentiated,not larger than 10 mm and limited to the mucosa/submucosa can be endoscopically resected. The management of duodenal NETs ranging between 10 and 20 mm needs an interdisciplinary discussion. Endoscopic ultrasound is the method of choice to determine tumor size and depth of infiltration. Surgery is recommended for well-differentiated duodenal NET tumors greater than 20 mm,for localized sporadic gastrinomas (of any size) and for localized poorly differentiated NE cancers. Surgery is recommended for any ileal NET. Advanced ileal NETs with a carcinoid syndrome are treated with longacting somatostatin analogs. This treatment significantly improves (progression-free) survival in patients with metastatic NETs of the ileum. For optimal NET management,tumor biology,type,localization and stage of the neoplasm,as well as the patient's individual circumstances have to be taken into account. | Hans Scherbl Robert T Jensen Guillaume Cadiot Ulrich Stlzel Gnter Klppel | 2010 | World Journal of Gastrointestinal Endoscopy2010，2，10： | 10 |
| 3 | TOTAL SYNTHESIS OF CLAUSENAMIDE显示文摘TOTAL SYNTHESIS OF CLAUSENAMIDETOTALSYNTHESISOFCLAUSENAMIDE￥ErChangRAO;HaoHONG;JiaChongCHENG;GuangZhongYANG;HanSenLIN;andLian... | Er Chang RAO Hao HONG Jia Chong CHENG Guang Zhong YANG Han Sen LIN andLiang HUANG(Institute of Mareia Medica. Chinese Academy of Medical Sciences1 Xian Nong Tan St .Beijing 100050) | 1994 | Chinese Chemical Letters1994，5，4： | 4 |
| 4 | 家猪体外胰蛋白酶消化关节软骨的7.0T磁共振T2弛豫时间图与量化分析显示文摘目的应用超高场7.0T磁共振T2加权成像技术、弛豫时间图和量化分析的方法评价体外胰蛋白酶消化与未消化家猪髌骨软骨T2弛豫时间的改变。方法选择10头家猪,各取左、右侧髌骨。左侧髌骨10个为实验组,右侧髌骨10个为对照组,分别浸泡于含有胰蛋白酶的PBS溶液及PBS中,4h后取出。利用7.0T磁共振机,分别采用多回波SE序列进行扫描,获得离体家猪髌骨关节软骨的T2加权图像。用自行编制的软件重构T2弛豫时间图,人工标注感兴趣区,分层定量测定关节软骨的T2值。结果经酶诱导消化的离体家猪髌骨关节软骨T2W成像清晰,呈分层状表现,对比度好,无异常伪影。对照组与实验组关节软骨T2WI关节软骨未见局部信号异常改变。与对照组比较,实验组软骨全层、表层、中间层T2值差异有统计学意义(P<0.05),而两者的深层与钙化层差异无统计学意义(P>0.05)。结论经胰蛋白酶诱导消化可引起退变软骨T2弛豫时间改变,在软骨的表层及中间层变化明显,提示T2弛豫时间是较敏感、特异的检测指标,可进一步应用于关节软骨退变的早期诊断。 | 周智洋 单鸿 邹学农 Steffen Ringgaard 邹立津 李海声 谢学斌 Hans StФdkilde-JФrgensen Cody Bünger | 2009 | 中国医学影像技术2009，，3： | 4 |
| 5 | Improving photoreduction of CO2 with water to CH4 in a novel concentrated solar reactor显示文摘CO_2 photoreduction is an attractive process which allows the storage of solar energy and synthesis of solar fuels. Many different photocatalytic systems have been developed, while the alternative photo-reactors are still insufficiently investigated. In this work, photoreduction of CO_2 with H_2O into CH_4 was investigated in a modified concentrating solar reactor, using TiO_2 and Pt/TiO_2 as the catalysts. The TiO_2 and Pt/TiO_2 samples were extensively characterized by different techniques including powder X-ray diffraction(XRD), N_2 adsorption/desorption and UV–vis absorption. The catalytic performance of the TiO_2 and Pt/TiO_2 samples in the gas phase was evaluated under unconcentrated and concentrated Xe-lamp light and nature solar light with different concentrating ratios. Various parameters of the reaction system and the catalysts were investigated and optimized to maximize the catalytic performance of CO_2 reduction system. Compared with the normal light irradiation, the TiO_2 and Pt/TiO_2 samples show higher photocatalytic activity(about 6–7 times) for reducing CO_2 into CH_4 under concentrated Xe-lamp light and nature solar light. In the range of experimental light intensity, it is found that the concentration of the light makes it suitable for the catalytic reaction, and increases the utilization efficiency of the TiO_2 and Pt/TiO_2 samples while does not decrease the quantum efficiency. | Sisi Han Yinfei Chen Stéphane Abanades Zekai Zhang | 2017 | Journal of Energy Chemistry2017，26，4： | 2 |
| 6 | 安捷伦液相/离子阱(XCT)质谱检测虾仁及家禽中的硝基呋喃代谢物显示文摘在液相/离子阱质谱上,利用液相/质谱/质谱方法对鸡肉及虾仁中硝基呋喃代谢物残留进行了定性定量分析.对于四种硝基呋喃代谢物,其定量限在0125到05μg·kg-1的范围内,分析结果完全满足欧盟的1μg·kg-1的最低检测限量的要求. | Bernhard wüst Christian Sauber Hans (J) A van Rhijn | 2004 | 环境化学2004，23，6： | 2 |
| 7 | Cilostazol for secondary stroke prevention:systematic review and meta-analysis显示文摘Background Stroke is one of the leading causes of death worldwide.Cilostazol,an antiplatelet and phosphodiesterase 3 inhibitor,has not been clearly established for ischaemic stroke use.We aim to determine the efficacy and safety of cilostazol for secondary stroke prevention.Methods MEDLINE,EMBASE,Cochrane Library,Web of Science and ClinicalTrials.gov were searched from inception to 25 September 2020,for randomised trials comparing the efficacy and safety of cilostazol monotherapy or dual therapy with another antiplatelet regimen or placebo,in patients with ischaemic stroke.Version 2 of the Cochrane risk-of-bias tool for randomised trials(RoB 2)was used to assess study quality.This meta-analysis was reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)statement.Results Eighteen randomised trials comprising 11429 participants were included in this meta-analysis.Most trials possessed low risk of bias and were of low heterogeneity.Cilostazol significantly reduced the rate of ischaemic stroke recurrence(risk ratio,RR=0.69,95%CI 0.58 to 0.81),any stroke recurrence(RR=0.64,95%CI 0.54 to 0.74)and major adverse cardiovascular events(RR=0.67,95%CI 0.56 to 0.81).Cilostazol did not significantly decrease mortality(RR=0.90,95%CI 0.64 to 1.25)or increase the rate of good functional outcome(Modified Rankin Scale score of 0–1;RR=1.07,95%CI 0.95 to 1.19).Cilostazol demonstrated favourable safety profile,significantly reducing the risk of intracranial haemorrhage(RR=0.46,95%CI 0.31 to 0.68)and major haemorrhagic events(RR=0.49,95%CI 0.34 to 0.70).Conclusions Cilostazol demonstrated superior efficacy and safety profiles compared with traditional antiplatelet regimens such as aspirin and clopidogrel for secondary stroke prevention but does not appear to affect functional outcomes.Future randomised trials can be conducted outside East Asia,or compare cilostazol with a wider range of antiplatelet agents. | Choon Han Tan Andrew GR Wu Ching-Hui Sia Aloysius ST Leow Bernard PL Chan Vijay Kumar Sharma Leonard LL Yeo Benjamin YQ Tan | 2021 | Stroke & Vascular Neurology2021，6，3： | 2 |
| 8 | Intravascular neutro-phil activation due to carbon monoxide poisoning显示文摘 | Thom SR Bhopale V Han ST | 2006 | Am J Physiol2006，174，11： | 1 |
| 9 | An investigation of brain processes supporting meditation显示文摘 | Klaus B. B?rentsen Hans St?dkilde-J?rgensen Bo Sommerlund Tue Hartmann Johannes Damsgaard-Madsen Mark Fosn?s Anders C. Green | | Cognitive Processing0，，： | 1 |
| 10 | Clonorchiasis and cholangiocarcinoma: etiologic and imaging diagnosis 显示文摘 | Choi BI Han J K Hong ST | 2004 | Clin Microbiol Rev2004，17，3： | 1 |
| 11 | Risk of hepatitis B reactiva- tion and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus(HBV) infection 显示文摘 | Mya DH Han ST Linn YC | 2012 | Ann Oncol2012，23，2： | 1 |
| 12 | Xanthine oxidoreductase and neurological sequelae of carbon monoxide poisoning显示文摘 | Han ST Bhopale VM Thom SR | 2007 | Toxicol Lett2007，170，2： | 1 |
| 13 | Iniravascular neutrophil specifically in hibits cytochrome coxidase of human mitochonchon- drial respiratory chain 显示文摘 | Alonso JR Bhopale VM Han ST el al | 2003 | Pharmacol Toxicol2003，93，： | 1 |
| 14 | Intravascular neutrophil activation due to carbon monoxide poisoning显示文摘 | Thom SR Bhopale VM Han ST | 2006 | Am J Respir Crit Care Med2006，174，11： | 1 |
| 15 | Intravascular neutrophil activation due to carbon monoxide poisoning显示文摘 | Thorn SR Bhopal VM Han ST | 2006 | Am J Respir Crit Care Med2006，174，11： | 1 |
| 16 | Intravascular neutrophil activation due to carbon monoxide poisoning显示文摘 | Thorn SR Bhopale VM Han ST | 2006 | Am J Respir Crit Care Med2006，174，： | 1 |
| 17 | Intravascular neutrophil activation due to carbon monoxide poisoning显示文摘 | Thom SR Bhopale VM Han ST | 2006 | Am J Respir Crit Care Med2006，174，11： | 1 |
| 18 | Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with eyclosporine-induced nephrotoxicity 显示文摘 | Yang JW Han ST Kim YS | 2010 | Transplant Proc2010，42，10： | 1 |
| 19 | Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis 显示文摘 | Choi BI Han JK Hong ST | 2004 | Clin Microbiol Rev2004，17，3： | 1 |
| 20 | Antimicrobial activity of mustard essential oil against Escherichia coli O157:H7 and Salmonella typhi显示文摘 | Mélanie Turgis Jaejoon Han Stéphane Caillet Monique Lacroix | 2009 | Food Control2009，，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员